Reuters logo
BRIEF-AmCad BioMed's product AmCAD-US gets marketing authorization in U.S.
May 31, 2017 / 1:37 AM / 6 months ago

BRIEF-AmCad BioMed's product AmCAD-US gets marketing authorization in U.S.

May 31(Reuters) - AmCad BioMed Corp

* Says it got marketing authorization in U.S. for its product AmCAD-US, which is used for early diagnosis of hepatic fibrosis

Source text in Chinese:goo.gl/1jHN6U

Further company coverage: (Beijing Headline News)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below